Kibow® Biotech to Present Its Breakthrough and Proven “Enteric Dialysis®” Technology at BIO 2018 International Convention, June 4-7 in Boston, MA, USA (www.BIO.org).
This annual convention is the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
Kibow® Biotech to Participate in The Pediatric Academic Societies (PAS) 2018 Meeting, May 5-8, 2018 in Toronto, Canada
Kibow Biotech is pleased to be exhibiting for the first time at The Pediatric Academic Societies (PAS) Meeting, May 5-8, 2018 in Toronto, Canada, (https://www.pas-meeting.org/) where it will introduce its plan to develop clinical studies for pediatric CKD patients using its innovative dietary supplement product, Renadyl™, the first and only kidney health supplement formulated and […]
On World Kidney Day Centaur Pharmaceuticals & Kibow® Biotech, USA, Announce a Strategic Alliance to Market Renadyl in India for Chronic Kidney Illness
– Prevalence of Chronic Kidney Illness in India is 17.2% and rising[1]. – Dialysis is a painful and expensive process with scarcely available resources. – This novel, US-patented, and clinically-tested product helps maintain healthy kidney functions.
Kibow Fortis® Recently Featured at the 2018 Integrative Healthcare Symposium in New York, NY.
Kibow® Biotech, the 20-year-old Research & Development Company and creator of the World’s first probiotic kidney health supplement Renadyl™, are announcing the availability of Kibow Fortis® a premium multi-fiber prebiotic supplement. Kibow Fortis, the world’s most comprehensive multi-fiber supplement is comprised of 6 prebiotic fibers. Other fiber supplements primarily use only psyllium husk and methylcellulose; […]
Global $10 Billion Probiotics Dietary Supplement Market 2017-2022 – Key Players are DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and Kibow Biotech
The “Probiotics Dietary Supplement Market – Forecasts from 2017 to 2022” report has been added to Research and Markets’ offering. Probiotics dietary supplement market is projected to witness a CAGR of 8.09% during the forecast period to reach a total market size of US$10.225 billion by 2022, increasing from US$6.928 billion in 2017 Shifting people […]